Giovanni Cecere - 18 Feb 2026 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: Chief Commercial Officer
Signature: By: /s/ Gerardo Hernandez, Attorney-in-Fact
Issuer symbol: TMDX
Transactions as of: 18 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 20 Feb 2026, 16:07:02 UTC
Previous filing: 12 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Cecere Giovanni	Chief Commercial Officer	C/O TRANSMEDICS GROUP, INC., 200 MINUTEMAN ROAD, ANDOVER	By: /s/ Gerardo Hernandez, Attorney-in-Fact	20 Feb 2026	0002110539

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Award	$0	+11,082	+139%	$0.000000	19,057	18 Feb 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMDX	Stock Option (Right to Buy)	Award	$0	+16,734		$0.000000	16,734	18 Feb 2026	Common Stock	16,734	$135.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of 11,082 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2	The option vests as to 25% of the shares underlying the option on February 18, 2027 and as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service.